XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Unaudited Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income $ 58,863 $ 135,857
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 45,235 54,648
Amortization of intangible assets 10,103 10,076
Noncash operating lease expense 7,995 13,878
Accretion of asset retirement obligation 107 131
Amortization of deferred financing costs 817 2,441
Amortization of original issue discount 1,289 437
Change in fair value of warrant liabilities (675) (1,809)
Stock-based compensation expense 5,683 13,948
Loss on disposal of specialty rental assets and other property, plant and equipment 80 137
Loss on extinguishment of debt   2,128
Deferred income taxes (314) 33,231
Provision for credit losses on receivables, net of recoveries 275 90
Changes in operating assets and liabilities    
Accounts receivable 19,578 (17,677)
Prepaid expenses and other assets 3,129 5,565
Accounts payable and other accrued liabilities (19,285) (19,138)
Deferred revenue and customer deposits (4,534) (106,112)
Operating lease obligation (7,821) (10,172)
Other non-current assets and liabilities 598 853
Net cash provided by operating activities 121,123 118,512
Cash flows from investing activities:    
Purchase of specialty rental assets (23,638) (53,662)
Purchase of property, plant, and equipment (324) (2,941)
Acquired intangible assets   (4,547)
Proceeds from sale of specialty rental assets and other property, plant and equipment 541 241
Net cash used in investing activities (23,421) (60,909)
Cash flows from financing activities:    
Principal payments on finance and finance lease obligations (1,223) (1,037)
Repayment of Senior Notes   (125,000)
Repurchase of Common Stock (21,894)  
Payment of issuance costs from warrant exchange   (1,504)
Proceeds from issuance of Common Stock from exercise of warrants 3 209
Proceeds from issuance of Common Stock from exercise of options 1,850 1,396
Payment of deferred financing costs   (1,423)
Taxes paid related to net share settlement of equity awards (2,615) (6,818)
Net cash used in financing activities (23,879) (134,177)
Effect of exchange rate changes on cash and cash equivalents (5) 5
Net increase (decrease) in cash and cash equivalents 73,818 (76,569)
Cash and cash equivalents - beginning of period 103,929 181,673
Cash and cash equivalents - end of period 177,747 105,104
Non-cash investing and financing activity:    
Non-cash change in accrued capital expenditures (2,771) (2,987)
Non-cash change in accrued repurchase of Common Stock (524)  
Non-cash change in finance lease obligations (1,372) $ (1,223)
Non-cash change in accrual of taxes for net share settlement of equity awards (47)  
Non-cash change in accrued distributions to noncontrolling interest $ (65)